Ardent Health (NYSE:ARDT) Given “Outperform” Rating at Leerink Partners

Ardent Health (NYSE:ARDT)‘s stock had its “outperform” rating restated by analysts at Leerink Partners in a report released on Friday, Benzinga reports. They currently have a $14.00 price objective on the stock. Leerink Partners’ target price would suggest a potential upside of 32.75% from the company’s previous close.

Other equities analysts have also recently issued reports about the stock. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $13.00 price objective on shares of Ardent Health in a research note on Thursday, August 6th. Zacks Research raised Ardent Health from a “strong sell” rating to a “hold” rating in a research note on Monday, September 7th. Wall Street Zen lowered Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday, July 12th. Weiss Ratings lowered Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Tuesday, August 11th. Finally, Guggenheim lifted their price objective on Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Seven research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Ardent Health presently has a consensus rating of “Hold” and a consensus target price of $12.95.

Ardent Health Trading Down 1.4%

Shares of NYSE ARDT traded down $0.15 during mid-day trading on Friday, hitting $10.55. The company’s stock had a trading volume of 26,959 shares, compared to its average volume of 450,054. The stock has a market cap of $1.49 billion, a price-to-earnings ratio of 19.29, a price-to-earnings-growth ratio of 3.03 and a beta of 0.71. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.10 and a quick ratio of 1.99. Ardent Health has a one year low of $7.71 and a one year high of $15.48. The company’s fifty day simple moving average is $10.79 and its 200-day simple moving average is $9.89.

Ardent Health (NYSE:ARDT) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.06). The business had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.59 billion. Ardent Health had a return on equity of 10.35% and a net margin of 1.22%.Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. On average, sell-side analysts anticipate that Ardent Health will post 0.96 earnings per share for the current fiscal year.

Institutional Trading of Ardent Health

A number of large investors have recently made changes to their positions in the company. Wedge Capital Management L L P NC lifted its holdings in Ardent Health by 212.3% during the second quarter. Wedge Capital Management L L P NC now owns 327,242 shares of the company’s stock worth $3,220,000 after acquiring an additional 222,447 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in shares of Ardent Health in the second quarter worth about $2,377,000. Hsbc Holdings PLC bought a new stake in shares of Ardent Health in the second quarter worth about $543,000. LSV Asset Management acquired a new stake in shares of Ardent Health during the fourth quarter worth about $963,000. Finally, Ieq Capital LLC bought a new position in shares of Ardent Health during the 2nd quarter valued at about $907,000.

Ardent Health Company Profile

Ardent Health is a U.S. healthcare provider that owns and operates hospitals, outpatient facilities and other healthcare services. The company delivers a broad range of medical care, including emergency services, inpatient and outpatient treatment, primary care, specialty care, surgical services, behavioral health and urgent care.

Headquartered in Nashville, Tennessee, Ardent serves communities through a network of hospitals and healthcare sites in several states, including Texas, Oklahoma, New Mexico and Kansas.